Sanofi/$SNY
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Sanofi
Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for approximately 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.
Ticker
$SNY
Sector
Primary listing
Employees
74,846
Headquarters
Website
Sanofi Metrics
BasicAdvanced
$107B
5.99
$7.44
0.37
$1.60
3.59%
Price and volume
Market cap
$107B
Beta
0.37
52-week high
$60.12
52-week low
$44.00
Average daily volume
4.9M
Dividend rate
$1.60
Financial strength
Current ratio
1.092
Quick ratio
0.66
Long term debt to equity
21.915
Total debt to equity
28.349
Dividend payout ratio (TTM)
61.08%
Interest coverage (TTM)
16.82%
Profitability
EBITDA (TTM)
14,731.751
Gross margin (TTM)
72.34%
Net profit margin (TTM)
16.72%
Operating margin (TTM)
20.27%
Effective tax rate (TTM)
17.33%
Revenue per employee (TTM)
$720,320
Management effectiveness
Return on assets (TTM)
4.65%
Return on equity (TTM)
6.66%
Valuation
Price to earnings (TTM)
5.99
Price to revenue (TTM)
1.002
Price to book
1.3
Price to tangible book (TTM)
7.35
Price to free cash flow (TTM)
6.562
Free cash flow yield (TTM)
15.24%
Free cash flow per share (TTM)
6.789
Dividend yield (TTM)
3.59%
Forward dividend yield
3.59%
Growth
Revenue change (TTM)
5.49%
Earnings per share change (TTM)
44.16%
3-year revenue growth (CAGR)
5.04%
10-year revenue growth (CAGR)
2.97%
3-year earnings per share growth (CAGR)
-1.35%
10-year earnings per share growth (CAGR)
7.03%
3-year dividend per share growth (CAGR)
4.99%
10-year dividend per share growth (CAGR)
3.47%
What the Analysts think about Sanofi
Analyst ratings (Buy, Hold, Sell) for Sanofi stock.
Sanofi Financial Performance
Revenues and expenses
Sanofi Earnings Performance
Company profitability
Sanofi News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Sanofi stock?
Sanofi (SNY) has a market cap of $107B as of March 10, 2026.
What is the P/E ratio for Sanofi stock?
The price to earnings (P/E) ratio for Sanofi (SNY) stock is 5.99 as of March 10, 2026.
Does Sanofi stock pay dividends?
Yes, the Sanofi (SNY) stock pays dividends to shareholders. As of March 10, 2026, the dividend rate is $1.59864 and the yield is 3.59%. Sanofi has a payout ratio of 61.08% on a trailing twelve-month basis.
When is the next Sanofi dividend payment date?
The next Sanofi (SNY) dividend payment date is unconfirmed.
What is the beta indicator for Sanofi?
Sanofi (SNY) has a beta rating of 0.37. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.